ADTRALZA sol inj 150 mg/ml ser pré 2 x 2 pce
7680682290017
CH-68229
D11AH07
07.15.0.
Reimbursement limitations:
ADTRALZA.01
Dermatite atopique - Adultes
Le traitement exige une garantie de prise en charge des frais …
1 / 3
google
Details
- Product number
- 6822901
- CPT
- -
- Packaging group
- 4
- Unit
- Fertigspritze(n)
- Composition
- tralokinumabum 150 mg, natrii acetas trihydricus, acidum aceticum glaciale, natrii chloridum, polysorbatum 80, aqua ad iniectabile, q.s. ad solutionem pro 1 ml corresp. natrium 2.977 mg.
Articles (1)
Adtralza 150mg/ml, Injektionslösung in einer Fertigspritze
Injektionslösung
4
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.977 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1121.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2022
Authorization holder
Leo Pharmaceutical Products Sarath Ltd.
8302 Kloten
Authorization information
- Swissmedic authorization number
- 68229
- Drug name
- Adtralza, Injektionslösung in einer Fertigspritze
- Galenic form
- LSINJ
- ATC Code
- D11AH07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 24/02/2022
- Authorization expiration date
- 23/02/2027
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ADTRALZA sol inj 150 mg/ml ser pré 2 x 2 pce
- Description (DE)
- ADTRALZA Inj Lös 150 mg/ml Fertspr 2 x 2 Stk
- Market launch
- 24/02/2022
- Narcotic (BTM)
- No